• Politics
  • Diversity, equity and inclusion
  • Financial Decision Making
  • Telehealth
  • Patient Experience
  • Leadership
  • Point of Care Tools
  • Product Solutions
  • Management
  • Technology
  • Healthcare Transformation
  • Data + Technology
  • Safer Hospitals
  • Business
  • Providers in Practice
  • Mergers and Acquisitions
  • AI & Data Analytics
  • Cybersecurity
  • Interoperability & EHRs
  • Medical Devices
  • Pop Health Tech
  • Precision Medicine
  • Virtual Care
  • Health equity

Spanish Doctors Speak on Mobile Uveitis Diagnostic Tool


Speaking at AAO 2016, they stressed that the program is designed to supplement careful diagnosis and cut costs.

Presented in Chicago at the American Academy of Ophthalmology 2016 Meeting, a novel mobile application may make it easier for clinicians to specifically diagnose uveitis.

Developed by a team of Spanish ophthalmologists led by José A. Gegúndez-Fernández (pictured left), Uvemaster is an intuitive, interactive Diagnostic Decision Support System (DDSS) intended to help general ophthalmologists respond to a patient’s specific symptoms.Containing a knowledge base of 88 uveitic syndromes with 76 related clinical items each, it contains 6,688 factors to be weighed and filtered by its inference engine.

After inputting the patient’s basic demographic information, doctors are able to mark all verifiably present and absent symptoms. The application then provides potential diagnoses, weighted for sensitivity, specificity, and PPV (proportion of sick among positives). To help clinicians further, the app has a section it calls “Uvepedia,” an information guide with an extensive backlog of lab tests, investigations, treatment options, and prognoses. While not intended as a standalone or a replacement for clinical discretion, its makers claim the app's diagnostic model has been found to have 96.6% predictive accuracy.

The application’s creators stress that the goal of the project is cost-reduction: in hopes of helping ophthalmologists more quickly and accurately diagnose uveitic conditions, the aim is to reduce the number of false positives, referrals, an incorrect treatments. Relatively inexpensive and publicly available, it can be set to either English or Spanish. Gegúndez says about 400 doctors have purchased the app to use in its first year on the market.

One of the creators, José M. Benítez-Castillo, underscored Uvemaster’s role as an aid rather than a replacement for expertise: “It helps. If you are an expert on uveitis, you may not need it, but for a general ophthalmologist, it can help.”

Related Videos
Craig Newman
Related Content
© 2023 MJH Life Sciences

All rights reserved.